glp-1 vs gip and GLP‐1, the two incretin hormones: Similarities and differences Biology of Incretins: GLP-1 and
Description
Designed to complement your GLP-1 journey
Compare semaglutide, tirzepatide, and retatrutide head to head
Think of your gut like a garden
No Commitment - Pause or Cancel Anytime
The global incretin-based drugs market was valued at USD 39.4 billion in 2025 and is projected to grow from USD 41.6 billion in 2026 to USD 72.6 billion by 2035, expanding at a CAGR of 6.4% between 2026 and 2035, driven by the rising prevalence of type 2 diabetes mellitus.
Conclusions This open-label, single-center pilot study suggests that GLP-1-RAs are an effective and safe treatment option for achieving significant weight loss with a favorable effect on headache, leading to reduced acetazolamide dosage in pwIIH
